Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Tomnl
    Junior Member
    • Jun 2013
    • 6

    #1

    Changes between Cufflinks/Cuffdiff version 2.0.2 and version 2.1.1

    Hey All

    I have analysed some RNA-Seq data for a mouse genome with both Cufflinks/Cuffdiff version 2.0 and 2.1 and get quite different results. I understand that there has been a major change for Cuffdiff between versions but the number of significant results identified in version 2.1 is quite striking, e.g version 2.0: 17 statistically (q) differential genes and version 2.1: 171 statistically (q) differential genes.

    I was wondering if this level of difference was expected and/or if anybody else has experienced similar differences between Cuffdiff versions?

    (I have posted a similar message on the tuxedo-tools Google group as well)

    Kind regards

    Tom

    Additional info:

    All genes significant (q) identified in version 2.0 were identified in 2.1.

    The study is comparing wild type mice to a known ENU induced mutant. 4 replicates were used for both wild type and mutant.

    Significantly expressed (q):
    v2.0 -> genes: 17 isoforms: 0 splicing: 90
    v2.1 -> genes: 171 isoforms: 78 splicing: 12

    Diff expressed genes (p adjusted) using edgeR: 22
    Diff expressed genes (p adjusted) using DESeq: 1

    Commands used when comparing Cuffdiff versions:

    /cufflinks-2.1.1.Linux_x86_64/cuffdiff -o /NGS/users/Thomas /Cufflinks_2.1.1/ -L WT,MUT -p 15 -c 0 --library-type=fr-unstranded <files>

    /cufflinks-2.0.2.Linux_x86_64/cuffdiff -o /NGS/users/Thomas/Cufflinks_2.0.2/ -L WT,MUT -p 15 -c 0 --library-type=fr-unstranded <files>

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Working...